Background: Diabetes affects a significant proportion of the population in the United States.
fasciocutaneous free flaps provide the benefits of robust blood supply and adequate soft tissue coverage. Technical refinements and postoperative monitoring have resulted in overall improved microsurgery outcomes and a lower incidence of complications, but the resulting morbidity and associated healthcare costs are significant when adverse events do occur (Cameron, 1985) .
While DM was historically considered a significant challenge to free flap reconstruction, there have been a multitude of conflicting reports with respect to its impact on outcomes. Although some studies found no significant association between DM and free flap failure (Bozikov & Arnez, 2006; Fichna et al., 2016; Miller et al., 2007; Wong et al., 2015) . Other reports have identified DM as a positive predictor of failure (Rosado, Cheng, Wu, & Wei, 2015; Valentini et al., 2008) .
Moreover, DM has been associated with increased rates of surgical site infections (SSI) (Bozikov & Arnez, 2006; Martin et al., 2016) , and prolonged hospital stay (Offodile, 2nd, Aherrera, & Guo, 2014) . However, the majority of previous studies have been limited to certain procedures or anatomical regions. This study evaluates the impact of DM on postoperative outcomes following commonly performed free flap reconstructions. 
| P A TI E NT S A ND M E TH ODS

| Statistical analysis
Continuous variables are reported as "mean 6 standard deviation", while categorical variables are reported as frequency and percentage to their corresponding groups. Univariate analysis was performed using v 2 or Fisher's exact test (N < 10) for categorical variables, and t tests for continuous variables. Statistical significance was defined as P < .05.
Multivariate logistic and linear regression models were used to control for potential confounders. Variables included in our models were: age, body mass index (BMI), postoperative hospital length of stay (LOS) smoking, American Society of Anesthesiology (ASA) class, procedure type, race, wound classification, surgical specialty, history of congestive heart failure (CHF), MI or percutaneous coronary intervention (PCI), hypertension, history of peripheral vascular disease (PVD) requiring surgery, chronic obstructive pulmonary disease (COPD), bleeding disorder, preoperative transfusion, preoperative wound infection, recent significant weight loss, recent steroid use, and history of DM. Wound and flap outcomes were also included in multivariate analysis of postoperative hospital LOS. A separate multivariate analysis of DM across outcomes significant on univariate analysis was also performed. A subgroup analysis of outcomes by anatomical flap location was subsequently performed, and included univariate and multivariate analyses.
All data analysis was performed using SPSS version 21.0 (IBM Corp., Armonk, NY).
| RE S U L TS
6030 patients were identified and stratified according to the presence or absence of DM, 5595 (92.8%) nondiabetic and 435 (7.2%) diabetic patients were included. Univariate analysis revealed significant differences between groups in age (P < .001), BMI (P < .001), gender (P < .001), ASA class 3 or higher (P < .001), race (P < .001), procedure type (P < .001), wound classification (P < .001), and surgical specialty performing the procedure (P < .001) ( Table 1 ). There were also significant differences in preoperative medical comorbidities, such as history of CHF (P 5 .05), recent MI (P 5 .04), previous PCI (P 5 .05), hypertension (P < .001), PVD requiring surgery (P < .03), severe COPD (P 5 .02),
open wound or wound infection (P < .001), and recent steroid use
Univariate analysis revealed no association between DM and flap failure (P 5 .82). However, diabetic patients presented significantly higher rates of deep incisional SSI (5.1 vs. 1.9%; P < .001), wound dehiscence (5.1 vs. 2.0%; P < .001), bleeding/transfusions up to 72 h postoperatively (21.1 vs.15.1%; P < .001), and increased postoperative LOS (5.7 6 5.1 vs. 8.0 6 7.8 days; P < .001) ( Table 2 ). There was no significant difference between groups in superficial incisional SSI or deep organ/space SSI. Univariate analysis of medical complications revealed significantly higher rates of stroke with neurological deficit (0.7 vs.
0.1%; P < .001), reintubation (2.5 vs. 0.8%; P < .001) and mechanical ventilation lasting longer than 48 h (4.4 vs. 1.3%; P < .001) among diabetic patients.
Multivariate regression showed no association between DM and free flap failure (P 5 .24). However, diabetic patients were more likely to develop deep incisional SSI (OR 5 1.35; 95% CI 1.23-1.47; P 5 .01), wound dehiscence (OR 5 1.17; 95% CI 1.02-1.24; P 5 .03), and required longer postoperative hospital stay (b 5 0.62; 95% CI 0.26-0.97; P < .001) ( Table 3) We then explored the relationship between DM and all outcomes that were significant on univariate analysis. A subgroup analysis of outcomes by flap location was subsequently performed, and identified 4285 free flaps to the breast, 920 free flaps to the head and neck, and 142 free flaps to the lower extremity. Table 5 shows the results of the univariate analysis, while Tables 6 and 7 show the results of the multivariate analysis.
| D ISC USSION
This study examined the impact of DM on free flap outcomes using the ACS-NSQIP database. Many groups have previously evaluated risk factors for flap failure and other (Bozikov & Arnez, 2006; Khouri et al., 1998; Offodile et al., 2014; Sanati-Mehrizy et al., 2016; Serletti, Higgins, Moran, & Orlando, 2000; Wong et al., 2015; Valentini et al., 2008) . Similarly, previous reports have attempted to identify the impact of DM on general surgical outcomes (Brown & Genoway, 2011; Chuah, Papamargaritis, Pillai, Krishnamoorthy, & le Roux, 2013; Huntington et al., 2016; Rosado et al., 2015) . However, due to conflicting results, the precise role of DM and other pre-existing vascular diseases remains unclear in free flap reconstruction (Valentini et al., 2008) . To our knowledge, our analysis constitutes the largest national multi-institutional study to date evaluating the impact of DM on postoperative outcomes following free flap reconstruction.
Historically, DM posed a major concern for surgeons performing free tissue transfer. Early studies describing diabetic pathophysiology, including nonatheromatous small vessel disease (Goldenberg, Alex, Joshi, & Blumenthal, 1959) and defective intimal repair mechanisms (Barr & Joyce, 1989 ) raised concerns regarding flap viability, flow obstruction, and anastomotic failure in this population. Increasing evidence of systemic and metabolic impairments in this population further contributed to the tempered enthusiasm for microsurgical However, DM remains controversial for microsurgeons due to conflicting published evidence. High complication rates have been reported in head and neck (Bozikov & Arnez, 2006; Rosado et al., 2015; Valentini et al., 2008) . Microsurgical reconstruction in diabetic patients; these include fistulas, flap infections, hematomas, thrombosis, and necrosis. In breast reconstruction (Miller et al., 2007) , comparable complication rates have been reported for diabetic and nondiabetic patients, and large prospective studies evaluating outcomes across all microsurgical procedures have not identified diabetes as an independent risk factor (Khouri et al., 1998) . Foot and ankle reconstruction literature is inconsistent, with some studies reporting increased complications (Ducic & Attinger, 2011) in diabetic patients, and others finding no such association (Fitzgerald O' Connor, Vesely, Holt, Jones, Thompson, & Hinchliffe, 2011; Wettstein, Schurch, Banic, Erni, & Harder, 2008) . This is compounded by methodological limitations, such as small sample sizes and a failure to utilize multivariate analysis to identify and control for confounders. Furthermore, definitions and grouping of surgical outcomes are not standardized, making comparisons between studies difficult. Consequently, consensus on how DM affects microsurgical outcomes has not been reached.
The impact of DM in this scenario is of particular importance given its rising prevalence, as well as the widespread use of free flap reconstruction in these patients. Elucidating the precise role of diabetes in free flap reconstruction will help guide management and inform surgical decision-making. Importantly, our analysis demonstrated that DM was not an independent risk factor for partial or total flap failure. In contrast, the existing literature is inconsistent regarding the relationship of diabetes and flap failure (Las et al., 2016; Nahabedian, Singh, Deune, Silverman, & Tufaro, 2004; Sanati-Mehrizy et al., 2016; Wong et al., 2015) , and varies widely depending on anatomical site and flap type (Las et al., 2016) . In head and neck surgery, overall flap failure has been reported five times higher in diabetic patients (Bozikov & Arnez, 2006; Rosado et al., 2015; Valentini et al., 2008) , but a wider report by Las et al. found no association between DM and free flap failure; however, foot and ankle flap failure rates were over nine times higher in diabetic patients (Las et al., 2016) . Clinical and preclinical evidence suggests that DM alone does not compromise free flap survival (Cooley, Hanel, Anderson, Foster, & Gould, 1992; Cooley, Hanel, Lan, Li, & Gould, 1992; Khouri et al., 1998; Wong et al., 2015) ; this is supported by a large-scale retrospective review in which flap survival rates were comparable between diabetic and nondiabetic patients (Sanati-Mehrizy et al., 2016) . However, certain pre-operative factors increase the chance of flap loss in diabetic patients, including PVD, history of angioplasty, and immunosuppression (Oh et al., 2013) . Whether this is (Ducic & Attinger, 2011) .
In our study DM was associated with increased rates of deep incisional (5.1 vs. 3.7%, P 5 .02). This is not surprising as DM is an independent risk factor for SSI across multiple surgical procedures (Martin et al., 2016) , likely resulting from a multifactorial pathogenesis that involves hyperglycemia, microvasculopathy, and immunosuppression.
As such, DM has been linked to higher rates of infection in oral cancer reconstruction, but this patient cohort was not limited to microsurgical repair (Liu et al., 2007) . In addition to the associated morbidity, mortality, and cost burden (Joynt, & Jha, 2013) , postoperative infections have been shown to predispose patients to flap loss (Las et al., 2016) . Interestingly, increased rates of superficial incisional SSI were not observed among patients with DM in our cohort. Given the presumed elevated infectious risk associated with surgery in diabetic patients supported by our study and others, there may be a potential role for perioperative antibiotic use in these patients. One study examining perioperative antibiotic use in 469 carpal tunnel release surgeries found that, while the protective effect of perioperative antibiotics was not significant, the effect was greater in diabetic patients (Ko, Zwiebel, Wilson, & Becker, 2017) . Moreover, antibiotics were more effective in poorly controlled diabetes, yielding a 3.8% infection reduction in patients with a hemoglobin A1C (HbA1C) >7% compared to a 0.2% decrease in patients with HbA1C <7%. This is in line with observations that poorly controlled DM leads to impaired phagocytic function and ability to fight infection (Lecube, Pachon, Petriz, Hernandez, & Simo, 2011) . While conclusions and recommendations cannot be made based off these results, perioperative antibiotic use may prove beneficial in these patients, and may merit consideration. These results also highlight the need for additional studies evaluating the role of perioperative and postoperative antibiotic prophylaxis in the diabetic patient population.
Our study also revealed increased rates of wound dehiscence in diabetic patients (P 5 .01). Animal data from wounds in diabetic rats have been shown to exhibit decreased tensile strength, collagen density, and contraction (Minossi et al., 2014) . Furthermore, wound infection is a common risk factor for dehiscence (Sandy-Hodgetts, Carville, & Leslie, 2015) , which might contribute to this finding.
Our study also shows that DM is associated with a significantly increased post-operative LOS, which may be consistent with evidence suggesting that diabetic patients exhibit delayed healing postoperatively (Ducic & Attinger, 2011; Haire-Joshu, Glasgow, Tibbs, & American Diabetes Association, 2004; Karp, Kasabian, Siebert, Eidelman, & Colen, 1994) . Extended hospital stays following microsurgery pose a tremendous clinical and financial burden (Fischer et al., 2013) . Impaired wound healing is a well-known complication of DM, and is responsible for the majority of chronic wounds and lower extremity amputations in the U.S. today (American Diabetes Association, 2013) . This pathogenesis involves hematological alterations (Jones & Peterson, 1981) and hyperglycemia-induced structural and functional modifications (Jeffcoate, Price, Harding, & International Working Group, 2004) in cells and connective tissue. Compromised wound healing remains a costly and complex clinical issue in this population (Bloomgarden, 2001) .
Although large, our study has several limitations. Most importantly, the ACS-NSQIP database records overall patient follow-up data for 30 days postoperatively, limiting our ability to capture the effect of DM on long-term outcomes after free flap reconstruction. Despite showing a significant association between diabetes and wound complications, the database lacks detailed wound descriptions beyond infection or dehiscence, such as the presence of abscesses or infected hematomas, or even donor vs. recipient site classification. We are also unable to determine whether wound complications were diagnosed prior to or following initial discharge, which could have potentially helped us better understand why there was a significant trend towards deep incisional SSI but not superficial incisional SSI in diabetic patients.
Importantly, information on type 1 versus type 2 DM status, time from diagnosis, and severity as detected by objective measures of glycemic control, such as HbA1C, would help determine the impact of these respective factors on postoperative outcomes. In the future, multicenter prospective studies are needed to thoroughly analyze the effect of DM on long-term outcomes in free flap surgery while accounting for these more specific details. 
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